Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Skin acetyl-CoA synthesis is crucial for overall lipid balance.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

The Free Androgen Index is important for diagnosing PCOS due to its strong link with symptoms and risk factors.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Certain inflammatory molecules and leptin may contribute to hair loss in cicatricial alopecia.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Androgen levels are more linked to body size in boys than girls.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Non-invasive methods can effectively monitor skin inflammation and cancer biomarkers.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Copeptin and cortisol levels are higher in alopecia areata patients, suggesting they could help diagnose and manage the condition.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

SNP profiling allows personalized skincare treatments for better results and fewer side effects.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

The BIOMAP glossary standardizes data to improve research on atopic dermatitis and psoriasis.

Adipose tissue-derived therapies show promise for improving osteoarthritis symptoms but need more research for safety and effectiveness.

Atopic dermatitis is linked to obesity, especially in severe cases.

Skin hormone levels change significantly after menopause.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

YAP1 helps fat cell formation by influencing the Hippo pathway.

Hair proteomics could be a promising non-invasive way to identify stress-related disorders.